Kamel LARIBI, Dr

French Innovative Leukemia Organisation

QC-verified· April 2026 PI on 1 trial

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

T-cell prolymphocytic leukemia

Clinical trials (1)

NCT04411043

Verify independently

ClinicalTrials.gov PI search for Kamel LARIBI, Dr

Other specialists for T-cell prolymphocytic leukemia

Peers ranked by clinical-trial PI role, publications, and verification quality.

David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Tapan M Kadia
M D Anderson Cancer Center
Texas
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Colleen Delaney, MD
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
CT
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
Ryotaro Nakamura
City of Hope Medical Center
California
Thomas C. Shea, MD
UNC Lineberger Comprehensive Cancer Center

See all specialists for T-cell prolymphocytic leukemia →

← Back to specialists directory